Immuneering (IMRX) Return on Sales (2020 - 2023)

Immuneering's Return on Sales history runs 4 years deep, the most recent figure standing at 1158.83% for Q3 2023.

• In Q3 2023, Return on Sales fell 115545.0% year-over-year to 1158.83%; the TTM figure through Sep 2023 stood at 1158.83% (down 115788.0% YoY), while the FY2022 annual figure was 1.59%, down 143.0% from the prior year.
• Return on Sales was 1158.83% for Q3 2023 at Immuneering, down from 13.55% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.06% in Q3 2020 to a low of 1158.83% in Q3 2023.
• Historically, Return on Sales has averaged 105.63% across 4 years, with a median of 0.64% in 2021.
• The sharpest annual moves came in 2021 and 2023: Return on Sales slipped 5 bps in 2021, then slumped 115545 bps in 2023.
• A 4-year view of Return on Sales shows it stood at 0.09% in 2020, then slumped by 560 bps to 0.58% in 2021, then tumbled by 51047 bps to 296.02% in 2022, then plunged by 291 bps to 1158.83% in 2023.
• The last three Return on Sales figures came in at 1158.83% (Q3 2023), 13.55% (Q2 2023), and 3.89% (Q1 2023), per Business Quant data.